What is Idexx Laboratories's revenue?

Idexx Laboratories (IDXX) generated $4.4B in revenue over the trailing twelve months, up 13.1% year over year.

Is Idexx Laboratories profitable?

Idexx Laboratories reported $1.1B in net income over the trailing twelve months, a 24.6% net margin.

What are Idexx Laboratories's profit margins?

Gross margin is 62.1% and operating margin is 31.6%, with a 24.6% net margin.

What is Idexx Laboratories's earnings per share?

Idexx Laboratories's diluted EPS over the trailing twelve months is $13.59.

Where does Idexx Laboratories's income statement data come from?

Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Idexx Laboratories IDXX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$4.3B+10.4%	$3.9B+6.5%	$3.66B+8.7%	$3.37B+4.7%
Total cost of revenue	$1.64B+8.3%	$1.52B+3.2%	$1.47B+7.9%	$1.36B+2.8%
Gross profit	$2.66B+11.8%	$2.38B+8.6%	$2.19B+9.3%	$2B+6.1%
Gross margin	61.8%+0.8pp	61%+1.2pp	59.8%+0.3pp	59.5%+0.8pp
Research and development	$251.21M+14.3%	$219.79M+15.1%	$190.95M-25.1%	$254.82M+58.3%
Selling and marketing	$643.55M+9.4%	$588.51M+4.0%	$566.07M+7.9%	$524.51M+7.8%
General and administrative	$404.79M-8.5%	$442.29M+31.7%	$335.83M+2.9%	$326.25M+5.4%
Other operating expenses	$1.3B+3.9%	$1.25B+14.4%	$1.09B-1.2%	$1.11B—
Total operating expenses	$1.3B+3.9%	$1.25B+14.4%	$1.09B-1.2%	$1.11B—
Operating income	$1.36B+20.5%	$1.13B+2.8%	$1.1B+22.1%	$898.77M-3.6%
Operating margin	31.6%+2.7pp	29%-1.0pp	30%+3.3pp	26.7%-2.3pp
Interest expense	$38.85M+24.5%	$31.21M-25.0%	$41.58M+4.3%	$39.86M+33.7%
Interest income	$3.01M-76.3%	$12.7M+126%	$5.63M+429%	$1.07M+145%
Income before income taxes	$1.32B+19.3%	$1.11B+4.6%	$1.06B+23.4%	$859.97M-4.7%
Income tax expense	$264.73M+19.3%	$221.96M+2.7%	$216.13M+19.5%	$180.88M+14.6%
Net income	$1.06B+19.3%	$887.87M+5.1%	$845.04M+24.4%	$679.09M-8.8%
Net margin	24.6%+1.8pp	22.8%-0.3pp	23.1%+2.9pp	20.2%-3.0pp
Diluted earnings per share	$13.08+22.6%	$10.67+6.1%	$10.06+25.1%	$8.04-6.6%
Basic earnings per share	$13.18+22.3%	$10.78+6.0%	$10.17+25.2%	$8.12-7.1%
Weighted-average shares, diluted	324.6M-2.7%	333.7M-0.7%	335.9M-1.0%	339.1M-2.2%
Weighted-average shares, basic	322.3M-2.5%	330.5M-0.5%	332.2M-0.9%	335.2M-1.8%
Interest income and other, net	$3.01M-76.3%	$12.7M+126%	$5.63M+429%	$1.07M+145%
Revenue From Contract With Customer Excluding Assessed Tax	$4.3B+10.4%	$3.9B+6.5%	$3.66B+8.7%	$3.37B+4.7%
EBITDA	$1.51B+19.6%	$1.26B+3.8%	$1.21B+19.9%	$1.01B-2.5%
EBITDA margin	35%+2.7pp	32.3%-0.8pp	33.1%+3.1pp	30%-2.2pp
EBIT	$1.36B+20.5%	$1.13B+2.8%	$1.1B+22.1%	$898.77M-3.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Idexx Laboratories.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Idexx Laboratories's revenue?: Idexx Laboratories (IDXX) generated $4.4B in revenue over the trailing twelve months, up 13.1% year over year.
Is Idexx Laboratories profitable?: Idexx Laboratories reported $1.1B in net income over the trailing twelve months, a 24.6% net margin.
What are Idexx Laboratories's profit margins?: Gross margin is 62.1% and operating margin is 31.6%, with a 24.6% net margin.
What is Idexx Laboratories's earnings per share?: Idexx Laboratories's diluted EPS over the trailing twelve months is $13.59.
Where does Idexx Laboratories's income statement data come from?: Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.